Diagnostic Procedure

Merck & Co. Partners with Guardant Health on Multi-Year Oncology Collaboration for Biomarker-Driven Cancer Therapies

5 days ago talkbio0Tagged companion diagnostics, Guardant Health, Infinity Smart platform, Liquid Biopsy, Merck, Oncology Collaboration

Merck; Guardant Health; oncology collaboration; liquid biopsy; companion diagnostics; Infinity Smart platform; Keytruda

Spotlight On: Five key oncology stories to watch in 2026

3 weeks ago talkbio0Tagged 2026, Antibody-Drug Conjugates, cancer research trends, CAR-T, Cell Therapy, Liquid Biopsy, Lymphocytes, Tumor-Infiltrating, mRNA cancer, Neoplasms, oncology decisions, precision oncology, Radiopharmaceuticals, T-Cell Receptor, United States Food and Drug Administration, Vaccines

oncology 2026; cancer research trends; FDA oncology decisions 2026; antibody-drug conjugates; radiopharmaceuticals; liquid biopsy; mRNA cancer vaccines; AI in oncology; cell therapies CAR-T TIL TCR; precision oncology

Noom Launches Proactive Health Microdose GLP-1 Program for Lower BMI Group Beyond Obesity Labels

1 month ago talkbio0Tagged Body mass index procedure, Glucagon-Like Peptide 1, Longevity, microdosing, Noom, Preventive Health Services, Proactive Health

Noom; GLP-1 microdosing; Proactive Health; BMI 21+; longevity; preventive health

PathAI’s AIM-MASH AI Assist Receives Historic FDA Qualification for MASH Clinical Trials

2 months ago talkbio0Tagged AI Assist, AIM-MASH, biomarker qualification, Biopsy of liver (procedure), Clinical Trials, Drug Development Tool, EMA qualification, Histology, MASH, MASLD, metabolic dysfunction-associated steatohepatitis, Nonalcoholic Steatohepatitis, PathAI, Pathology, Qualification, United States Food and Drug Administration

PathAI; AIM-MASH; AI Assist; FDA qualification; Drug Development Tool; biomarker qualification; MASH; MASLD; NASH; metabolic dysfunction-associated steatohepatitis; AI pathology; clinical trials; EMA qualification; liver biopsy; histology

Astrin Biosciences Announces Scientific Advisory Board to Advance Early Cancer Detection Leveraging AI and Proteomics

2 months ago talkbio0Tagged Astrin Biosciences, cancer intelligence, Detection, Liquid Biopsy, Proteomics, Scientific Advisory Board

Astrin Biosciences; Scientific Advisory Board; early cancer detection; AI; proteomics; liquid biopsy; cancer intelligence

Recent news on ACIP’s hepatitis B birth‑dose recommendation

2 months ago talkbio0Tagged ACIP, birth dose, Centers for Disease Control and Prevention (U.S.), Clinical Decision-Making, Hepatitis B, hepatitis B policy change, Immunization Schedule, Infant, pregnancy screening, Vaccination

ACIP; hepatitis B; birth dose; infant vaccination; shared clinical decision-making; CDC immunization schedule; pregnancy screening; hepatitis B policy change

EDAP Receives FDA 510(k) Clearance for Advanced Focal One Robotic HIFU System Enhancements

2 months ago talkbio0Tagged algorithm, Clearance, Edap, Malignant neoplasm of prostate, Medical Devices, robotic HIFU, United States Food and Drug Administration

EDAP; FDA 510(k) clearance; Focal One; robotic HIFU; high intensity focused ultrasound; ultrasound imaging; prostate cancer treatment; AI algorithms; medical devices

Sirona Medical Receives FDA 510(k) Clearance for Advanced Imaging Suite, Expanding PET-CT and Class II Medical Device Functionality

3 months ago talkbio0Tagged Advanced Imaging Suite, capabilities, Class II Medical Device, Clearance, image management, PET/CT scan, radiological imaging, regulatory approval, Sirona Medical, United States Food and Drug Administration

Sirona Medical; FDA 510(k) clearance; Advanced Imaging Suite; Radiological imaging; PET-CT capabilities; Class II medical device; image management; regulatory approval